Comparative analysis of p73 and p53 regulation and effector functions

Journal of Cell Biology

Volumn 147, Issue 4, 1999, Pages 823-830

  Fang, Li ^a   Lee, Sam W ^b   Aaronson, Stuart A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

DNA damage; p53; p73; Replicative senescence; Tumor suppression

Indexed keywords

GENE PRODUCT; PROTEIN P53; PROTEIN P73; UNCLASSIFIED DRUG;

ALLELE; APOPTOSIS; ARTICLE; CANCER INHIBITION; DNA DAMAGE; EFFECTOR CELL; GENE CONTROL; GENE MUTATION; GENE OVEREXPRESSION; GENE REPLICATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE; DNA DAMAGE; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT PROTEINS; TETRACYCLINE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 0033571275     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.147.4.823     Document Type: Article

References (49)

1. Agami, R., G. Blandino, M. Oren, and Y. Shaul. 1999. Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature. 399:809-813.
2. Balint, E., S. Bates, and K.H. Vousden. 1999. Mdm2 binds p73α without targeting degradation. Oncogene. 18:3923-3929.
3. Band, V., S. Dalal, L. Delmolino, and E.J. Androphy. 1993. Enhanced degradation of p53 protein in HPV-E6 and BPV-1 E6 immortalized human mammary epithelial cells. EMBO (Eur. Mol. Biol. Organ.) J. 12:1847-1852.
4. Bargonetti, J., I. Reynisdottir, P.N. Friedman, and C. Prives. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6:1886-1898.
5. Brown, D.R., S. Deb, M. Munoz, M.A. Subler, and S.P. Deb. 1993. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein. Mol. Cell. Biol. 13:6849-6857.
6. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554.
7. Di Como, C.J., C. Gaiddon, and C. Prives. 1999. p73 function is inhibited by tumor derived p53 mutants in mammalian cells. Mol. Cell Biol. 19:1438-1449.
8. Di Leonardo, A., S.P. Linke, K. Clarkin, and G.M. Wahl. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540-2551.
9. Dimri, G.P., X. Lee, and G. Basile. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:9363-9367.
10. Dobbelstein, M., S. Wienzek, C. Konig, and J. Roth. 1999. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene. 18:2101-2106.
11. Fang, L., M. Igarashi, J. Leung, M. Sugrue, S. Lee, and S. Aaronson. 1999. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in tumor cells lacking functional p53. Oncogene. 18:2789-2797.
12. Fields, B.N., D.M. Knipe, and P.M. Howley. 1996. Virology. J.B. Lippincott, Co., Philadelphia, PA. 3,216 pp.
13. Gong, J.G., A. Costanzo, H.Q. Yang, G. Melino, W.G.J. Kaelin, M. Levrero, and J.Y.J. Wang. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:806-809.
14. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:5547-5551.
15. Gottlieb, T.M., and O. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta. 1287:77-102.
16. Harris, C.C., and M. Hollstein. 1993. Clinical implication of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1318-1327.
17. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature. 387:296-299.
18. Hollstein, M., K. Rice, M.S. Greenblatt, T. Soussi, R. Fuchs, T. Sorlie, E. Hovig, B. Smith-Sorensen, R. Montesano, and C.C. Harris. 1994. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22:3551-3555.
19. Hoppe-Seyler, F., and K. Butz. 1993. Repression of endogenous p53 transactivation function in Hela cervical carcinoma cells by human papillomavirus type 16 E6, human mdm2, and mutant p53. J. Virol. 67:3111-3117.
20. Jiang, D., A. Srinivasan, G. Lozano, and P.D. Robbins. 1993. SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene. 8:2805-2812.
21. Jost, C.A., M.C. Marin, and W.G.J. Kaelin. 1997. p73 is a human p53-related protein that can induce apoptosis. Nature. 389:191-194.
22. Kaghad, M., H. Bonnet, A. Yang, L. Creancier, J.C. Biscan, A. Valent, A. Minty, P. Chalon, J.M. Lelias, X. Dumont, et al. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:809-819.
23. Ko, L.J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
24. Kubbutat, M.H., S.N. Jones, and K.H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature. 387:299-303.
25. Lane, D.P., and L.V. Crawford. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature. 278:261-263.
26. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell. 88: 323-331.
27. Levine, A.J., M.C. Wu, A. Chang, A. Silver, E. Attiyeh, J. Lin, and C.B. Epstein. 1995. The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype. Ann. N.Y. Acad. Sci. 768:111-128.
28. Linzer, D.I., and A.J. Levine. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 17:43-52.
29. Marin, M.C., C.A. Jost, M.S. Irwin, J.A. DeCaprio, D. Caput, and W.G.J. Kaelin. 1998. Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol. 18:6316-6324.
30. Mietz, J.A., T. Unger, J.M. Huibregtse, and P.M. Howley. 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO (Eur. Mol. Biol. Organ.) J. 11:5013-5020.
31. Momand, J., G.P. Zambetti, D.C. Olsen, D. George, and A.J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 69:1237-1245.
32. Nelson, W.G., and M.B. Kastan. 1994. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1815-1823.
33. Nigro, J.M., S.J. Baker, A.C. Preisinger, J.M. Jessup, R. Hostetter, K. Cleary, S.H. Bigner, N. Davidson, S. Baylin, P. Devilee, et al. 1989. Mutations in the p53 gene occur in diverse human tumor types. Nature. 342:705-708.
34. Oliner, J.D., J.A. Pietenpol, S. Thiagalingam, J. Gyuris, K.W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature. 362:857-860.
35. Osada, M., M. Ohba, C. Kawahara, C. Ishioka, R. Kanamaru, I. Katoh, Y. Ikawa, Y. Nimura, A. Nakagawara, M. Obinata, and S. Ikawa. 1998. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med. 4:839-843.
36. Rieger, K.M., A.F. Little, J.M. Swart, W.V. Kastrinakis, J.M. Fitzgerald, D.T. Hess, J.A. Libertino, and I.C. Summerhayes. 1995. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br. J. Cancer. 72:683-690.
37. Roth, J., C. Konig, S. Wienzek, S. Weigel, S. Ristea, and M. Dobbelstein. 1998. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins. J. Virol. 72:8510-8516.
38. Scheffner, M., B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley. 1990. The E6 oncoprotein encoded by human papillomaviruses types 16 and 18 promotes the degradation of p53. Cell. 63:1129-1136.
39. Senoo, M., N. Seki, M. Ohira, S. Sugano, M. Watanabe, M. Tachibana, T. Tanaka, Y. Shinkai, and H. Kato. 1998. A second p53-related protein, p73L, with high homology to p73. Biochem. Biophys. Res. Commun. 248:603-607.
40. Sharma, S., I. Schwarte Waldhoff, H. Oberhuber, and R. Schafer. 1993. Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes. Cell Growth Differ. 4:861-869.
41. Sugrue, M.M., D.Y. Shin, S.W. Lee, and S.A. Aaronson. 1997. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA. 94:9648-9653.
42. Trink, B., K. Okami, L. Wu, V. Sriuranpong, J. Jen, and D. Sidransky. 1998. A new human p53 homologue. Nat. Med. 4:747-748.
43. Werness, B.A., A.J. Levine, and P.M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:76-79.
44. Yang, A., M. Kaghad, Y. Wang, E. Gillett, M.D. Fleming, V. Dotsch, N.C. Andrews, D. Caput, and F. McKeon. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell. 2:305-316.
45. Yew, P.R., and A.J. Berk. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early E1B protein. Nature. 357:82-85.
46. Yoshikawa, H., M. Nagashima, M.A. Khan, M.G. McMenamin, K. Hagiwara, and C.C. Harris. 1999. Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene. 18:3415-3421.
47. Yuan, Z.M., H. Shioya, T. Ishiko, X.G. Sun, J.J. Gu, Y.Y. Huang, H. Lu, S. Kharbanda, R. Weichselbaum, and D. Kufe. 1999. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature. 399: 814-817.
48. Zeng, X.Y., L.H. Chen, C.A. Jost, R. Maya, D. Keller, X.J. Wang, W.G.J. Kaelin, M. Oren, J.D. Chen, and H. Lu. 1999. MDM2 suppress p73 function without promoting p73 degradation. Mol. Cell. Biol. 19:3257-3266.
49. Zhu, J., J. Jiang, W. Zhou, and X. Chen. 1998. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58:5061-5065.